George Arida is a Managing Director with a focus on the firm’s healthcare practice.
George currently serves as the Board Chair for Zystor Therapeutics and Nerites and as a member of the Boards of Directors at Celleration, Chromatin and ProCertus BioPharm. He also serves on the Board of the Mid-America Healthcare Investors Network, an association of over forty regional venture capital firms active in early stage healthcare investing.
George previously served as the CFO for a financial consulting and brokerage firm. Prior to this, he spent five years at U.S. Filter Corporation in management and technical marketing positions, four years with Betz Laboratories in technical sales and field service management, and two years at Alar Engineering as a Process Engineer.
George has a Bachelor of Science degree in Chemical Engineering from the University of Illinois at Urbana-Champaign and a Master of Business Administration degree with high honors from the University of Chicago.